In order to validate the tissue analysis based on partitioning of the 812 breast cancer tissue using the 35% thresholds to define high and low HER2 expression, we next compared the transcript levels of the 3350 genes that were differentially expressed in our definition of HER2+/− tumor tissues to independent RNA-seq data [18]. This evidence concerns the gene ERBB2 and breast carcinoma.